NSRX - Nasus Pharma Ltd

QQQ $ 629.78 $ -3.11 (-0.49 %)

DIA $ 472.70 $ -2.66 (-0.56 %)

SPY $ 681.88 $ -2.29 (-0.33 %)

TLT $ 89.68 $ 0.07 (0.08 %)

GLD $ 366.72 $ 0.05 (0.01 %)

Previous Close

$ 7.61

Open

$ 8.00

Bid

$ 7.33 x 3

Ask

$ 8.34 x 1,000

Day's Range

$ 7.58 - $ 8.40

52 Week Range

$ 5.90 - $ 9.99

Volume

2,044

Average Volume

Market Cap

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (nm)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Earlier Today: Nasus Pharma Executes Compr...
10/08/2025 14:26:13

12 Health Care Stocks Moving In Friday's A...
10/03/2025 21:05:59

12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

Laidlaw & Co. Initiates Coverage On Nasus ...
09/29/2025 12:22:01

Laidlaw & Co. analyst Yale Jen initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Targ...

Nasus Pharma Prices $10M Initial Public Of...
08/13/2025 11:38:08

The Company intends to use the net proceeds from the initial public offering for furthering the development of its intranasal E...